LOC643623 Inhibitors
The designation LOC643623 Inhibitors refers to a specific class of chemical compounds meticulously designed to modulate the activity of LOC643623, a molecular target currently under scrutiny in scientific research. These inhibitors are intricately crafted through principles rooted in medicinal chemistry, with a primary focus on selectively interfering with the normal functions of LOC643623 within cellular processes. The structural features of LOC643623 Inhibitors undergo a meticulous optimization process, often incorporating computational modeling and structure-activity relationship studies, to ensure precise molecular configurations that facilitate effective binding to the target.
The significance of LOC643623 Inhibitors lies in their potential to disrupt the biochemical activities associated with LOC643623, a molecular entity presumed to play a role in various biological pathways. Researchers in this field delve into the three-dimensional structure of LOC643623 and its binding interactions with inhibitors, aiming to unravel the intricate molecular mechanisms underlying inhibition. The study of LOC643623 Inhibitors contributes to a broader understanding of cellular processes, offering insights into the roles played by LOC643623 in diverse biological pathways and expanding our knowledge of the regulatory networks governing cellular activities. This research not only advances our comprehension of the molecular intricacies surrounding LOC643623 but also contributes to the broader scientific understanding of molecular targets and their involvement in fundamental cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor that can alter the chromatin structure, potentially affecting the transcription of genes including those that produce lncRNAs like lincRNA 2523. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA is another histone deacetylase inhibitor that can lead to changes in chromatin state, potentially influencing the expression patterns of various genes, including lncRNAs. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This compound is a DNA methyltransferase inhibitor that could lead to genomic DNA hypomethylation, potentially affecting the transcription of lncRNAs like lincRNA 2523. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide has been shown to inhibit the transcription of various genes by affecting RNA polymerase activity. This could reduce the expression of lncRNAs such as lincRNA 2523. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to GC-rich DNA sequences, potentially inhibiting the binding of transcription factors and thereby affecting the transcription of certain genes, which may include lncRNAs like lincRNA 2523. | ||||||
Chromomycin A3 | 7059-24-7 | sc-200907 | 10 mg | $260.00 | ||
Similar to Mithramycin A, Chromomycin A3 binds DNA and could inhibit the transcription of genes by blocking transcription factor access, potentially reducing the expression of lncRNAs. | ||||||
A77 1726 | 163451-81-8 | sc-207235 | 10 mg | $80.00 | 14 | |
Teriflunomide is an active metabolite of leflunomide that inhibits dihydroorotate dehydrogenase, leading to a reduction in pyrimidine synthesis, which could indirectly affect RNA synthesis and lncRNA levels. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB inhibits the positive transcription elongation factor b (P-TEFb), which is necessary for the transition into productive elongation by RNA polymerase II, potentially affecting lncRNA expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphatidylinositol 3-kinases (PI3K), which are involved in signaling pathways that can affect transcription and may influence lncRNA levels indirectly. | ||||||